An Extension Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome

• Status: Terminated
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate of the long-term safety and efficacy of KCT-0809 in dry eye patients with Sjögren's syndrome.

• Phase: Phase 3

Details

• Lead Sponsor: Kissei Pharmaceutical Co., Ltd.
• Treatments: Ophthalmic Solutions

Criteria

Inclusion Criteria:

• Dry eye patients with Sjögren's syndrome finished KCT1301 study

Exclusion Criteria:

• Patients with poor adherence to medication of study drug in KCT1301 study